Q1 2026 · 13F-HR
Blue Owl Capital Holdings LPholdings as filed
Filed 2026-05-14 · accession 0001193125-26-223563
$372.2M
Reported value
75
Positions
2026-03-31
Period end
The Brief · Blue Owl Capital Holdings LP · Q1 2026
AI · grounded in 13F
Blue Owl Capital Holdings LP closed its position in BLK, reducing exposure by $1.01B. The fund established a new position in AKTS worth $56.56M and added CRVS with a $7.97M investment. Other activity included closing positions in RPTX and PCOR while increasing its stake in MPLT by 207.57%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 01021M104 | AKTS | AKTIS ONCOLOGY INC | $56.6M | 15.2% | 3,161,348 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $32.0M | 8.61% | 7,120,007 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $30.1M | 8.08% | 4,416,353 | Common | SOLE |
| 67090S108 | NCDL | NUVEEN CHURCHILL DIRECT LEND | $27.3M | 7.33% | 2,143,626 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $27.1M | 7.29% | 1,909,764 | Common | SOLE |
| 69121K104 | OBDC | BLUE OWL CAPITAL CORPORATION | $22.6M | 6.08% | 2,045,070 | Common | SOLE |
| 56565P103 | MPLT | MAPLIGHT THERAPEUTICS INC | $20.5M | 5.49% | 1,005,929 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $15.6M | 4.18% | 2,941,525 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $13.3M | 3.58% | 5,089,015 | Common | SOLE |
| 43538H103 | HLLY | HOLLEY INC | $13.0M | 3.49% | 4,236,888 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT INC | $11.8M | 3.16% | 912,594 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $8.0M | 2.14% | 545,000 | Common | SOLE |
| 206787103 | CNDT | CONDUENT INC | $6.4M | 1.73% | 5,036,595 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $6.3M | 1.70% | 302,638 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $5.6M | 1.50% | 1,347,932 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $5.3M | 1.44% | 61,455 | Common | SOLE |
| 20451W901 | CMPS | COMPASS PATHWAYS PLC | $5.1M | 1.38% | 1,804,504 | Common | SOLE |
| 45258H106 | IMMX | IMMIX BIOPHARMA INC | $5.0M | 1.34% | 547,552 | Common | SOLE |
| 45175G207 | IMA | IMAGENEBIO INC | $4.8M | 1.29% | 959,337 | Common | SOLE |
| 17878Y207 | CVEO | CIVEO CORP CDA | $4.8M | 1.28% | 180,475 | Common | SOLE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $4.6M | 1.25% | 506,722 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $4.4M | 1.18% | 1,419,912 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $4.3M | 1.16% | 215,000 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $4.2M | 1.14% | 1,904,666 | Common | SOLE |
| 697947109 | PVLA | PALVELLA THERAPEUTICS INC NE | $3.9M | 1.05% | 31,259 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $3.7M | 1.01% | 2,969,199 | Common | SOLE |
| 85571B105 | STWD | STARWOOD PPTY TR INC | $2.7M | 0.73% | 158,545 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $2.6M | 0.70% | 733,568 | Common | SOLE |
| 30054Y107 | EVMN | EVOMMUNE INC | $2.3M | 0.62% | 100,000 | Common | SOLE |
| 24703L202 | DELL | DELL TECHNOLOGIES INC | $2.3M | 0.61% | 13,899 | Common | SOLE |
| 517125900 | LRMR | LARIMAR THERAPEUTICS INC | $1.9M | 0.51% | 975,700 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $1.9M | 0.51% | 150,000 | Common | SOLE |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $1.7M | 0.47% | 333,877 | Common | SOLE |
| 98262P200 | WW | WW INTL INC | $1.3M | 0.35% | 95,634 | Common | SOLE |
| 29286M113 | — | ENGENE HOLDINGS INC | $1.3M | 0.35% | 511,177 | Common | SOLE |
| 293792107 | EPD | ENTERPRISE PRODS PARTNERS L | $1.2M | 0.32% | 31,290 | Common | SOLE |
| 29103K100 | FLD | FOLD HLDGS INC | $1.1M | 0.30% | 856,632 | Common | SOLE |
| 87169M113 | OPTXW | SYNTEC OPTICS HLDGS INC | $867,383 | 0.23% | 803,132 | Common | SOLE |
| 57055L206 | MRKR | MARKER THERAPEUTICS INC | $720,525 | 0.19% | 554,250 | Common | SOLE |
| 603170901 | MLYS | MINERALYS THERAPEUTICS INC | $590,000 | 0.16% | 200,000 | Common | SOLE |
| 654484153 | NIOBW | NIOCORP DEVS LTD | $524,964 | 0.14% | 320,100 | Common | SOLE |
| 20454B904 | CMPX | COMPASS THERAPEUTICS INC | $500,000 | 0.13% | 400,000 | Common | SOLE |
| 104932116 | BNAIW | BRAND ENGAGEMENT NETWORK INC | $416,702 | 0.11% | 1,666,808 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $363,031 | 0.10% | 1,718 | Common | SOLE |
| G75398118 | RZLVW | REZOLVE AI PLC | $202,204 | 0.05% | 235,121 | Common | SOLE |
| 724078209 | PIPR | PIPER SANDLER COMPANIES | $185,863 | 0.05% | 2,428 | Common | SOLE |
| 020952107 | AMOD | ALPHA MODUS HLDGS INC | $145,809 | 0.04% | 394,078 | Common | SOLE |
| 29273V100 | ET | ENERGY TRANSFER L P | $102,792 | 0.03% | 5,326 | Common | SOLE |
| 171756109 | DAIC | CID HOLDCO INC | $94,751 | 0.03% | 557,361 | Common | SOLE |
| 142152107 | CAI | CARIS LIFE SCIENCES INC | $84,233 | 0.02% | 4,711 | Common | SOLE |
| 00857W308 | — | VODAFONE GROUP PLC | $80,672 | 0.02% | 5,371 | Common | SOLE |
| 020952115 | AMODW | ALPHA MODUS HLDGS INC | $74,187 | 0.02% | 1,854,665 | Common | SOLE |
| 92686J906 | VKTX | VIKING THERAPEUTICS INC | $68,000 | 0.02% | 50,000 | Common | SOLE |
| 824430300 | SHFS | SHF HOLDINGS INC | $62,995 | 0.02% | 75,897 | Common | SOLE |
| 38046W204 | GOCO | GOHEALTH INC | $61,563 | 0.02% | 40,770 | Common | SOLE |
| 00791X209 | AEON | AEON BIOPHARMA INC | $41,506 | 0.01% | 42,353 | Common | SOLE |
| G1331C112 | BGLWW | BLUE GOLD LTD | $35,000 | 0.01% | 175,000 | Common | SOLE |
| 84445C118 | SLND/WS | SOUTHLAND HLDGS INC | $34,412 | 0.01% | 860,302 | Common | SOLE |
| G7606H116 | RDZNW | ROADZEN INC | $31,500 | 0.01% | 225,000 | Common | SOLE |
| 86366E906 | GPCR | STRUCTURE THERAPEUTICS INC | $25,000 | 0.01% | 100,000 | Common | SOLE |
| 09263B116 | BKSY/WS | BLACKSKY TECHNOLOGY INC | $14,000 | 0.00% | 350,000 | Common | SOLE |
| 68062P906 | OLMA | OLEMA PHARMACEUTICALS INC | $10,000 | 0.00% | 200,000 | Common | SOLE |
| G0705H111 | BDMDW | BAIRD MED INVT HLDGS LTD | $9,000 | 0.00% | 100,000 | Common | SOLE |
| 171756117 | DAICW | CID HOLDCO INC | $8,890 | 0.00% | 444,515 | Common | SOLE |
| 23834J110 | DAVEW | DAVE INC | $7,763 | 0.00% | 28,750 | Common | SOLE |
| 88165K119 | TVGNW | TEVOGEN BIO HLDGS INC | $6,000 | 0.00% | 200,000 | Common | SOLE |
| 485859201 | KPLT | KATAPULT HOLDINGS INC | $5,736 | 0.00% | 5,421 | Common | SOLE |
| 854936119 | SDSTW | STARDUST PWR INC | $2,667 | 0.00% | 16,666 | Common | SOLE |
| 53271X116 | LIMNW | LIMINATUS PHARMA INC. | $2,000 | 0.00% | 50,000 | Common | SOLE |
| M7S64L107 | PGYWW | PAGAYA TECHNOLOGIES LTD | $1,946 | 0.00% | 48,661 | Common | SOLE |
| 98400V119 | XBPEW | XBP GLOBAL HOLDINGS INC | $1,487 | 0.00% | 24,778 | Common | SOLE |
| G9503X111 | WALDW | WALDENCAST PLC | $1,333 | 0.00% | 33,333 | Common | SOLE |
| 738920115 | ASBPW | ASPIRE BIOPHARMA HLDGS INC | $1,000 | 0.00% | 50,000 | Common | SOLE |
| 09174P113 | BTMWW | BITCOIN DEPOT INC | $1,000 | 0.00% | 50,000 | Common | SOLE |
| 485859110 | KPLTW | KATAPULT HOLDINGS INC | $0 | — | 400,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.